Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR-T100 gel in actinic keratosis
NCT01493921Phase 3Completed
- Sponsor
- G&E Herbal Biotechnology
- Start
- Oct 2011
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in actinic keratosis (AK) comparing SR-T100 gel with Vehicle gel (2 arms). Primary endpoint: Comparison of SR-T100 gel effect with vehicle gel on efficacy and tolerability at 24 weeks. Started Oct 2011; status: completed.
02
Drugs
SR-T100
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01493921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493921.